Skip to content

PTSD in children and adolescents

TL;DR — Development changes symptom expression, informant agreement, dependence on caregivers and treatment delivery. A 2025 network meta-analysis included 70 RCTs (n=5,528): TF-CBT g=1.06 (95% CI .86–1.26), EMDR g=.86 (.54–1.18), multidisciplinary treatment g=.88 (.53–1.23), and non-trauma-focused treatment g=.95 (.62–1.28), each versus passive control (Hoppen 2025, PMID 39630422). TF-CBT had the strongest and most durable evidence, but 74% of trials tested TF-CBT, creating an evidence-volume imbalance. Trauma-exposed youth meta-analysis estimated PTSD incidence 15.9% (11.5–21.5) (Alisic 2014, PMID 24785767).

Developmental assessment

Young children may express reenactment, separation fears, regression, irritability or somatic distress; caregiver and child reports may diverge. Instruments and thresholds must be age-validated (Maercker 2022, PMID 35780794) (Alisic 2014, PMID 24785767).

Treatment

TF-CBT combines skills, gradual exposure/trauma narrative, cognitive processing, caregiver work and safety enhancement. The NMA supports short-, mid- and long-term benefit (Hoppen 2025, PMID 39630422).

Caregiver role

Caregiver involvement can support practice and safety but may be complicated when the caregiver is unavailable, traumatised or implicated. Trials should report who participated.

EMDR and alternatives

EMDR and other interventions showed benefit versus passive control, but longer-term evidence was less developed than TF-CBT (Hoppen 2025, PMID 39630422). Network estimates should not be read as decisive head-to-head superiority.

Safeguarding

Ongoing abuse, exploitation, unsafe housing and suicidality change priorities. Treatment cannot substitute for protection.

Acceptability

Pediatric dropout is markedly lower than the adult figures reported on dropout-and-nonresponse. Across 40 RCTs, dropout from any treatment or active control arm was 11.7% (95% CI 9.0–14.6), 11.2% (95% CI 8.2–14.6) from evidence-based treatment (TF-CBTs and EMDR) and 12.8% (95% CI 7.6–19.1) from non-trauma-focused treatments or controls, with no significant difference in odds of dropout between modalities; group rather than individual delivery, and lay rather than professional delivery, were associated with less dropout (Simmons 2021, PMID 34377359). The common claim that trauma-focused work drives children out of treatment is not supported by the trial data.

Medication

Adult SSRI approvals do not automatically apply to children, and the guideline evidence base treats them as separate questions: NICE commissioned a dedicated evidence review of pharmacological interventions for the prevention and treatment of PTSD in children, distinct from its adult drug reviews (National Guideline Alliance 2018, PMID 32757557). The pediatric drug trials that exist are small and informant-discordant — a 26-child randomized trial of sertraline after burns found benefit on parent-reported but not child-reported symptoms (Stoddard 2011, PMID 22040192) — against 70 RCTs and 5,528 patients on the psychological side (Hoppen 2025, PMID 39630422). Pediatric medication decisions require age-specific efficacy and harm evidence that largely does not exist.

Pooling warning

A trial of general anxiety symptoms after adversity is not a pediatric PTSD trial. Full and subthreshold PTSD should be reported separately.

Quantitative anchors

Measure Estimate Population/method Source
Post-trauma incidence 15.9% (95% CI 11.5–21.5) 43 samples; n=3,563 (Alisic 2014, PMID 24785767)
Pediatric NMA 70 RCTs; n=5,528 Full/subthreshold PTSD ≤19 (Hoppen 2025, PMID 39630422)
TF-CBT vs passive g=1.06 (95% CI .86–1.26) Treatment endpoint (Hoppen 2025, PMID 39630422)
EMDR vs passive g=.86 (.54–1.18) Treatment endpoint (Hoppen 2025, PMID 39630422)
Parent-involved TF-CBT vs non-TF g=.35 (.04–.66) Sensitivity analysis (Hoppen 2025, PMID 39630422)
Pediatric dropout, all arms 11.7% (95% CI 9.0–14.6) 40 RCTs (Simmons 2021, PMID 34377359)
Pediatric dropout, TF-CBT/EMDR 11.2% (95% CI 8.2–14.6) Same review; no significant difference by modality (Simmons 2021, PMID 34377359)
Pediatric sertraline after burns benefit on parent- but not child-reported symptoms n=26 (Stoddard 2011, PMID 22040192)

Evidence ledger

The ledger lists the live-retrieved records used to bound this page. Inclusion does not make every record equally probative; design, population and comparator remain decisive.

PMID Year Evidence contribution Scope caution
39630422 2025 Psychological Interventions for Pediatric Posttraumatic Stress Disorder: A Systematic Review and Network Meta-Analysis. Synthesis: preserve included-population and certainty limits
24785767 2014 Rates of post-traumatic stress disorder in trauma-exposed children and adolescents: meta-analysis. Synthesis: preserve included-population and certainty limits
7492257 1995 Posttraumatic stress disorder in the National Comorbidity Survey. PTSD-specific record; inspect design and population
24990362 2015 An Update on Posttraumatic Stress Disorder in Children and Adolescents. PTSD-specific record; inspect design and population
19635237 2009 Epidemiology of child traumatic stress. PTSD-specific record; inspect design and population
10795604 2000 Posttraumatic stress disorder: epidemiology and health-related considerations. PTSD-specific record; inspect design and population
38225917 2024 [PTSD and Complex PTSD - Assessment, management and treatment]. PTSD-specific record; inspect design and population
10439203 1999 Posttraumatic stress disorders in children and adolescents. PTSD-specific record; inspect design and population
40783299 2025 Prevalence of Post-Traumatic Stress Disorder (PTSD) in autistic children or young people (CYP) and adults: A systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
11909008 2002 Post-traumatic stress disorder in children and adolescents: epidemiology, diagnosis and treatment options. PTSD-specific record; inspect design and population
18474199 2008 Post-traumatic stress disorder and its treatment in children and adolescents. PTSD-specific record; inspect design and population
39540207 2024 Trauma exposure and ICD-11 PTSD and CPTSD in a Greenlandic adolescent population. PTSD-specific record; inspect design and population
34242737 2022 Systematic Review and Meta-analysis: Prevalence of Posttraumatic Stress Disorder in Trauma-Exposed Preschool-Aged Children. Synthesis: preserve included-population and certainty limits
12108814 2002 Posttraumatic stress disorder among adolescent earthquake victims in Taiwan. PTSD-specific record; inspect design and population
26028651 2016 Systematic Review on Post-Traumatic Stress Disorder Among Survivors of the Wenchuan Earthquake. Synthesis: preserve included-population and certainty limits
15513767 2004 Interventions for post-traumatic stress disorder in children and adolescents. PTSD-specific record; inspect design and population
20940670 2010 Suicidal behavior in adolescents with post-traumatic stress disorder. PTSD-specific record; inspect design and population
34479132 2021 Child-reported posttraumatic stress symptoms and attrition from therapy. PTSD-specific record; inspect design and population
33111174 2021 Prevalence of post-traumatic stress disorder in caregivers of pediatric neurosurgical patients. PTSD-specific record; inspect design and population
20441729 2010 Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. Synthesis: preserve included-population and certainty limits
27359192 2017 Posttraumatic Stress Disorder Diagnosis in Young Children With Burns. PTSD-specific record; inspect design and population
32063234 2020 Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Synthesis: preserve included-population and certainty limits
32284821 2020 Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
26574151 2016 Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
21352105 2007 Early intervention for post-traumatic stress disorder. PTSD-specific record; inspect design and population
34377359 2021 A meta-analysis of dropout from evidence-based psychological treatment for post-traumatic stress disorder (PTSD) in children and young people. Trial dropout, not routine-care dropout
22040192 2011 A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children. n=26; informant discordance
32757557 2018 Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children: Post-traumatic stress disorder: Evidence review E. Guideline evidence review, not a primary study
35780794 2022 Complex post-traumatic stress disorder. Review; includes assessment and treatment in children and adolescents

Interpretation guardrails

  • Trauma exposure, post-traumatic symptoms, acute stress disorder, DSM-5 PTSD, ICD-11 PTSD and ICD-11 complex PTSD are not interchangeable populations.
  • A mixed-anxiety or transdiagnostic estimate is labelled as such; only a source’s PTSD stratum can be treated as a PTSD effect.
  • Comorbid depression is measured separately and cross-linked to the depression condition; it is not absorbed into PTSD.
  • Waitlist, treatment-as-usual, attention control and active treatment answer different causal questions.
  • Registration, statistical significance and diagnostic loss do not respectively prove completion, clinical importance or functional recovery.
  • This page synthesizes research and does not provide individual medical advice.

Minimum extraction frame for studies on this topic

Field What must be retained Why it changes interpretation
Diagnostic system DSM version, ICD version, full/subthreshold Case mix is not interchangeable
Diagnostic method Structured interview, clinician judgment, self-report cutoff Screening is not diagnosis
Index trauma Type, timing, repetition, direct/indirect/occupational Conditional risk and phenotype differ
Population Civilian, veteran, refugee, child/adolescent, mixed Transportability is empirical
Baseline severity Mean, SD, range and exclusion threshold Ceiling and floor effects alter change
CPTSD status ITQ/ICD-11 definition and DSO score Complexity cannot be inferred from trauma count
Comorbidity Depression, GAD, SUD, pain, TBI measured separately Shared symptoms can distort effects
Comparator Waitlist, usual care, attention, active treatment The estimand changes with comparator
Treatment dose Sessions offered/attended, duration, homework Assignment is not exposure
Outcome Symptoms, diagnosis, response, function, sleep Outcomes are not interchangeable
Time point End point and prespecified follow-up windows Acute benefit may not persist
Missing data Denominator, reasons, imputation and estimand Attrition can bias rank and magnitude
Adverse events Definitions, ascertainment and arm-level counts Absence of reporting is not absence of harm
Therapist/context Training, fidelity, allegiance, setting Delivery is part of the intervention
Funding/conflicts Sponsor role and analytic independence Especially material for proprietary packages

Claims this page does not make

  • It does not infer PTSD from trauma exposure alone.
  • It does not treat a self-report cutoff as equivalent to a structured diagnosis.
  • It does not convert a pooled anxiety-disorder effect into a PTSD effect.
  • It does not convert a depression outcome in a comorbid sample into a PTSD outcome.
  • It does not infer superiority from a statistically significant within-group change.
  • It does not infer equivalence from a non-significant between-group test.
  • It does not infer effectiveness from trial registration or mechanistic plausibility.
  • It does not assume military, civilian, refugee and pediatric estimates transport unchanged.
  • It does not average conflicting estimates that use different definitions.
  • It does not treat lack of adverse-event reporting as evidence of safety.

Evidence-updating triggers

Trigger Required response
New diagnostic revision Recalculate which populations prior estimates represent
New head-to-head RCT Compare against active treatment, not only waitlist
New individual-participant synthesis Revisit effect modifiers and transportability
Registry status change Verify results and linked publication before changing conclusions
Guideline update Separate evidence review from panel recommendation
Regulatory decision Record decision date and source; do not infer from efficacy papers
Safety signal Re-extract denominator, ascertainment and exposure time by arm
Contradictory replication Display estimates side by side; do not average definitions

Evidence updates should preserve the prior estimate and explain why the new study changes—or does not change—the inference.

Open questions

  • Which TF-CBT components and caregiver configurations drive durable benefit? (Hoppen 2025, PMID 39630422)
  • How should trials measure developmental harms, school functioning and family outcomes? (Hoppen 2025, PMID 39630422)
  • Which early interventions prevent chronic PTSD without over-treating natural recovery? (Alisic 2014, PMID 24785767)

References

  1. Hoppen TH, et al. Psychological Interventions for Pediatric Posttraumatic Stress Disorder: A Systematic Review and Network Meta-Analysis. JAMA Psychiatry. 2025;82(2):130-141. PMID 39630422
  2. Alisic E, et al. Rates of post-traumatic stress disorder in trauma-exposed children and adolescents: meta-analysis. Br J Psychiatry. 2014;204:335-40. PMID 24785767
  3. Kessler RC, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-60. PMID 7492257
  4. Connor DF, et al. An Update on Posttraumatic Stress Disorder in Children and Adolescents. Clin Pediatr (Phila). 2015;54(6):517-28. PMID 24990362
  5. Fairbank JA, et al. Epidemiology of child traumatic stress. Curr Psychiatry Rep. 2009;11(4):289-95. PMID 19635237
  6. Hidalgo RB, et al. Posttraumatic stress disorder: epidemiology and health-related considerations. J Clin Psychiatry. 2000;61 Suppl 7:5-13. PMID 10795604
  7. Mijaljica G, et al. [PTSD and Complex PTSD - Assessment, management and treatment]. Lakartidningen. 2024;121:23091. PMID 38225917
  8. Perry BD, et al. Posttraumatic stress disorders in children and adolescents. Curr Opin Pediatr. 1999;11(4):310-6. PMID 10439203
  9. Mansour H, et al. Prevalence of Post-Traumatic Stress Disorder (PTSD) in autistic children or young people (CYP) and adults: A systematic review and meta-analysis. Clin Psychol Rev. 2025;120:102621. PMID 40783299
  10. Donnelly CL, et al. Post-traumatic stress disorder in children and adolescents: epidemiology, diagnosis and treatment options. Paediatr Drugs. 2002;4(3):159-70. PMID 11909008
  11. Najjar F, et al. Post-traumatic stress disorder and its treatment in children and adolescents. Curr Psychiatry Rep. 2008;10(2):104-8. PMID 18474199
  12. Banzon T, et al. Trauma exposure and ICD-11 PTSD and CPTSD in a Greenlandic adolescent population. Eur J Psychotraumatol. 2024;15(1):2425242. PMID 39540207
  13. Woolgar F, et al. Systematic Review and Meta-analysis: Prevalence of Posttraumatic Stress Disorder in Trauma-Exposed Preschool-Aged Children. J Am Acad Child Adolesc Psychiatry. 2022;61(3):366-377. PMID 34242737
  14. Hsu CC, et al. Posttraumatic stress disorder among adolescent earthquake victims in Taiwan. J Am Acad Child Adolesc Psychiatry. 2002;41(7):875-81. PMID 12108814
  15. Hong C, et al. Systematic Review on Post-Traumatic Stress Disorder Among Survivors of the Wenchuan Earthquake. Trauma Violence Abuse. 2016;17(5):542-561. PMID 26028651
  16. Carr A Interventions for post-traumatic stress disorder in children and adolescents. Pediatr Rehabil. 2004;7(4):231-44. PMID 15513767
  17. Ganz D, et al. Suicidal behavior in adolescents with post-traumatic stress disorder. Minerva Pediatr. 2010;62(4):363-70. PMID 20940670
  18. Wamser-Nanney R Child-reported posttraumatic stress symptoms and attrition from therapy. Child Abuse Negl. 2021;121:105266. PMID 34479132
  19. Beaudoin W, et al. Prevalence of post-traumatic stress disorder in caregivers of pediatric neurosurgical patients. Childs Nerv Syst. 2021;37(3):959-967. PMID 33111174
  20. Strawn JR, et al. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry. 2010;71(7):932-41. PMID 20441729
  21. Stoddard FJ, et al. Posttraumatic Stress Disorder Diagnosis in Young Children With Burns. J Burn Care Res. 2017;38(1):e343-e351. PMID 27359192
  22. Mavranezouli I, et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2020;50(4):542-555. PMID 32063234
  23. Lewis C, et al. Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Eur J Psychotraumatol. 2020;11(1):1729633. PMID 32284821
  24. Cusack K, et al. Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2016;43:128-41. PMID 26574151
  25. Bryant RA Early intervention for post-traumatic stress disorder. Early Interv Psychiatry. 2007;1(1):19-26. PMID 21352105
  26. Maercker A, et al. Complex post-traumatic stress disorder. Lancet. 2022;400(10345):60-72. PMID 35780794
  27. Simmons C, et al. A meta-analysis of dropout from evidence-based psychological treatment for post-traumatic stress disorder (PTSD) in children and young people. Eur J Psychotraumatol. 2021;12(1):1947570. PMID 34377359
  28. Stoddard FJ Jr, et al. A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children. J Child Adolesc Psychopharmacol. 2011;21(5):469-77. PMID 22040192
  29. National Guideline Alliance (UK). Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children: Post-traumatic stress disorder: Evidence review E. London: NICE; 2018. PMID 32757557